Literature DB >> 22094120

Novel micelles based on amphiphilic branched PEG as carriers for fenretinide.

Isabella Orienti1, Guendalina Zuccari, Mirella Falconi, Gabriella Teti, Nicola A Illingworth, Gareth J Veal.   

Abstract

This study reports on the preparation and evaluation of amphiphilic macromolecules based on branched polyethylene glycol covalently linked with alkyl hydrocarbon chains. These macromolecules easily dissolved in an aqueous environment, with formation of micellar nanoaggregates endowed with hydrophobic inner cores capable of hosting fenretinide by complexation. The complexes increased fenretinide aqueous solubility, while hindering its release as a free drug in an aqueous environment. Particle size analysis indicated dimensional suitability of the complexes for intravenous administration. Neuroblastoma cell lines (SH-SY5Y and NGP) exhibited increased sensitivity to fenretinide in complex as compared to free drug, associated with higher intracellular concentrations of fenretinide observed after treatment with the complex. Transmission electronic microscopy images revealed endocytosis of the micellar complex. Moreover, fenretinide conversion to its metabolite 4-oxo-fenretinide was delayed in cells treated with the complex, further supporting the hypothesis that fenretinide may be absorbed by micellar transport and exposed to the cytoplasm for conversion to its metabolite only after micelle destabilization.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22094120     DOI: 10.1016/j.nano.2011.10.008

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  6 in total

1.  Microencapsulation of amorphous solid dispersions of fenretinide enhances drug solubility and release from PLGA in vitro and in vivo.

Authors:  Kari Nieto; Susan R Mallery; Steven P Schwendeman
Journal:  Int J Pharm       Date:  2020-06-07       Impact factor: 5.875

Review 2.  Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.

Authors:  Shizhu Chen; Keni Yang; Ruslan G Tuguntaev; Anbu Mozhi; Jinchao Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanomedicine       Date:  2015-12-17       Impact factor: 5.307

3.  Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.

Authors:  Fabio Pastorino; Chiara Brignole; Monica Loi; Daniela Di Paolo; Annarita Di Fiore; Patrizia Perri; Gabriella Pagnan; Mirco Ponzoni
Journal:  Front Oncol       Date:  2013-08-05       Impact factor: 6.244

4.  Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model.

Authors:  Sandra Durante; Isabella Orienti; Gabriella Teti; Viviana Salvatore; Stefano Focaroli; Anna Tesei; Sara Pignatta; Mirella Falconi
Journal:  Oncotarget       Date:  2014-07-15

5.  Preparation and Evaluation of a Novel Class of Amphiphilic Amines as Antitumor Agents and Nanocarriers for Bioactive Molecules.

Authors:  Isabella Orienti; Mirella Falconi; Gabriella Teti; Mark A Currier; Jiang Wang; Mitch Phelps; Timothy P Cripe
Journal:  Pharm Res       Date:  2016-07-25       Impact factor: 4.200

6.  A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model.

Authors:  Isabella Orienti; Ferro Nguyen; Peng Guan; Venkatadri Kolla; Natalia Calonghi; Giovanna Farruggia; Michael Chorny; Garrett M Brodeur
Journal:  Drug Des Devel Ther       Date:  2019-12-19       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.